Pri-Med Southwest

Houston, TX | May 1-3, 2019

George R. Brown Convention Center

Explore Online CME Agenda

Disclosures

The following financial relationships have been disclosed by faculty:  

Financial Disclosures

Martin J. Abrahamson, MD, FACP
Novo Nordisk, Advisory Board
Sandeep K. Agarwal, MD, PhD
No financial disclosures
Anoop Agrawal, MD
No financial disclosures
Eliot A. Brinton, MD, FAHA, FNLA
Akcea Therapeutics, Advisory Board; Akcea Therapeutics, Speakers Bureau; Amarin Pharma Inc., Advisory Board; Amarin Pharma Inc., Speakers Bureau; Amgen, Advisory Board; Amgen, Speakers Bureau; AstraZeneca, Advisory Board; Boehringer Ingelheim Pharmaceuticals, Inc., Speakers Bureau; Esperion Therapeutics, Inc., Advisory Board; Kowa Pharmaceuticals America, Inc., Advisory Board; Kowa Pharmaceuticals America, Inc., Speakers Bureau; Novo Nordisk Inc., Speakers Bureau; Regeneron Pharmaceuticals, Inc., Advisory Board; Regeneron Pharmaceuticals, Inc., Speakers Bureau; Sanofi US, Advisory Board; Sanofi US, Speakers Bureau
M. Susan Burke, MD, FACP
No financial disclosures
Sarah G. Candler, MD, MPH
No financial disclosures
Katherine Carroll, MD
No financial disclosures
Yvonne I. Chu, MD, MBA
No financial disclosures
Harry Dao Jr., MD
No financial disclosures
Dave deBronkart
No financial disclosures
Frank J. Domino, MD
No financial disclosures
Susan A. Eicher, MD
No financial disclosures
Rola El-Serag, MD
No financial disclosures
Sergio Fazio, MD, PhD
Akcea Therapeutics, Consultant; Amarin Pharma Inc., Consultant; Amgen Inc., Consultant; AstraZeneca, Consultant; Esperion Therapeutics, Inc., Consultant; Novartis Pharmaceuticals Corporation, Consultant
Joslyn Fisher, MD,MPH
No financial disclosures
Katherine E. Galluzzi, DO, CMD, FACOFP
No financial disclosures; No financial disclosures
Ty J. Gluckman, MD, FACC, FAHA
AbbVie Inc., Consultant; Teva Pharmaceuticals, Consultant
Stephen B. Greenberg, MD, MACP
No financial disclosures
Richard J. Hamill, MD
No financial disclosures
Albert C. Hergenroeder, MD
No financial disclosures
Joseph S. Kass, MD, JD, FAAN
Biogen Inc., Contracted Research; Genentech, Inc./Roche Holding AG, Contracted Research; Novartis AG, Contracted Research; Takeda Pharmaceutical Company Ltd., Contracted Research
David L. Katz, MD, MPH, FACPM, FACP
No financial disclosures
Frank Lavernia, MD
Janssen Pharmaceuticals, Advisory Board
Petros Levounis, MD, MA
No financial disclosures
Lee A. Lindquist, MD, MPH, MBA
No financial disclosures
Michelle Look, MD, FAAFP, DABOM
Novo Nordisk Inc., Speakers Bureau
Richard A. Martinello, MD
Genentech, Advisory Board
Steve Messineo, DPT
No financial disclosures
Richard E. Pratley, MD
AstraZeneca, Consultant; GlaxoSmithKline, Consultant; Glytec, LLC, Consultant; Janssen Pharmaceuticals, Inc., Consultant; Janssen Pharmaceuticals, Inc., Contracted Research; Lexicon Pharmaceuticals, Contracted Research; Ligand Pharmaceuticals, Inc., Consultant; Ligand Pharmaceuticals, Inc., Contracted Research; Lilly USA, LLC, Consultant; Lilly USA, LLC, Contracted Research; Merck & Co., Inc., Consultant; Merck & Co., Inc., Contracted Research; Mundipharma, Consultant; Novo Nordisk Inc., Consultant; Novo Nordisk Inc., Contracted Research; Novo Nordisk Inc., Speakers Bureau; Pfizer Inc., Consultant; Sanofi US, Consultant; Sanofi US, Contracted Research
Rajeev Raghavan, MD
No financial disclosures
Alan M. Rapoport, MD
Amgen, Advisory Board; Amgen, Speakers Bureau; Amneal, Advisory Board; Autonomic Technologies, Consultant; Electrocore, Speakers Bureau; Promius Pharma, Advisory Board; Satsuma Pharmaceuticals, Inc, Advisory Board; Teva Pharmaceuticals, Advisory Board; Teva Pharmaceuticals, Speakers Bureau; Zosano Pharma Corp., Advisory Board
Marc Robinson, MD
No financial disclosures
Daniel Z. Sands, MD, MPH
Biotricity, Advisory Board; Biotricity, Ownership Interest; Conversa Health, Consultant; Conversa Health, Ownership Interest; Health Vector, Advisory Board; Health Vector, Ownership Interest; Medisafe, Consultant; Wego Health, Advisory Board; Wego Health, Ownership Interest
R. Michelle Schmidt, MD, MPH
No financial disclosures
Christopher D. Still, DO, FACP, FTOS
Ethicon EndoSurgery, Inc., Advisory Board; Ethicon EndoSurgery, Inc., Consultant; Ethicon EndoSurgery, Inc., Contracted Research; Novo Nordisk Inc., Advisory Board; Novo Nordisk Inc., Speakers Bureau
Alan C. Swann, MD
No financial disclosures
Jeff Unger, MD, FACE, FAAFP
Abbott Laboratories, Advisory Board; Abbott Laboratories, Contracted Research; Abbott Laboratories, Speakers Bureau; GlaxoSmithKline, Contracted Research; Janssen Pharmaceuticals, Inc., Advisory Board; Janssen Pharmaceuticals, Inc., Contracted Research; Janssen Pharmaceuticals, Inc., Speakers Bureau; Novo Nordisk Inc., Advisory Board; Novo Nordisk Inc., Contracted Research; Novo Nordisk Inc., Ownership Interest; Novo Nordisk Inc., Speakers Bureau
Charles Vega, MD, FAAFP
No financial disclosures
Karol E. Watson, MD, PhD
Amgen, Inc., Consultant; Boehringer Ingelheim, Consultant; Boehringer Ingelheim, Speakers Bureau; Esperion, Consultant; Kowa, Consultant

Other Disclosures

Pamela Kushner, MD, FAAFP (Reviewer):  Advisory Board and Speaker's Bureau for AstraZeneca, GlaxoSmithKline, and Janssen Pharmaceuticals, Inc.; Consulting Fee and Services Provided for Promotional Purposes for AstraZeneca and Janssen Pharmaceuticals.

All other non-faculty contributors involved in the planning, development, editing and review of the content have disclosed no relevant financial relationships.